Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE). Non-interventional Study to Evaluate Reviparin for Prevention of Thrombosis and Thromboembolism in General and Orthopedic Surgery (Here: for Perioperative Bridging of Oral Anticoagulation in Interventional Procedures) in General Practices

NCT02579122 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.

NCT NCT02579122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE). Non-interventional Study to Evaluate Reviparin for Prevention of Thrombosis and Thromboembolism in General and Orthopedic Surgery (Here: for Perioperative Bridging of Oral Anticoagulation in Interventional Procedures) in General Practices
Lead sponsor
Mylan Inc.
Phase
Observational
Overall status
Terminated
Start date
October 31, 2015
Completion date
July 31, 2016
Enrollment
77 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism